Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2423studies indexed1086with human data145registered trials2091carry a numeric findingLibrarian added 0 studies today
Showing 24 studiesSortNewest indexed ▾
B
grade
Prognostic risk modeling based on integrated multi-omics analysis identifies CRY2 as a key regulator in tumor immunity and patient survival in colorectal cancer.
P21 (P021) · Annals of medicine · 2026 · Observational
The study found that a prognostic model based on ferroptosis and lipid metabolism can predict survival outcomes in colorectal cancer, with CRY2 identified as a key regulator.
HR > 1.1, p < 0.001 for RiskScore as an independent predictor of overall survival.
B
grade
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.
P21 (P021) · Nature medicine · 2026 · ObservationalTop journal
Over half of the patients treated with daraxonrasib showed genomic alterations linked to resistance, suggesting the need for combination therapies to address these changes.
59% of patients (26 of 44) showed treatment-emergent genomic alterations in the RAS signaling pathway.
Showing 24 of 24